What is the mechanism by which eltrombopag causes thrombocytopenia?

Eltrombopag is an oral thrombopoietin (TPO) receptor agonist, mainly used to treat thrombocytopenia caused by chronic immune (idiopathic) thrombocytopenic purpura (ITP). However, the mechanism by which eltrombopag causes thrombocytopenia is actually a relatively complex issue because eltrombopag itself is designed to increase platelet counts, not decrease them.

Long-term use of the same drug may cause the body to adapt to the drug, causing the drug's effect to weaken or disappear. This phenomenon is called drug resistance. If a patient develops resistance to eltrombopag, the effect of the drug will be reduced or even ineffective, resulting in a decrease in platelet count instead of an increase.

Bone marrow failure refers to a disease state in which the hematopoietic function of the bone marrow is reduced or lost. When a patient's bone marrow hematopoietic stem cells are damaged or inhibited, reduced platelet production occurs. In this case, even taking eltrombopag may not effectively increase platelet counts.

ITPA patient's immune system mistakenly attacks and destroys platelets, causing the number of platelets to drop. If a patient's immune system remains active and continues to destroy platelets while taking eltrombopag, the platelet count may not increase effectively.

If the patient fails to take the medication on time, stops the medication at will or the dose of the medication is insufficient, it may lead to unstable drug concentration in the body, thus affecting the efficacy. In this case, the platelet count may also decrease instead of rising.

Infections or inflammatory diseases may cause abnormal fluctuations in platelet numbers. Different individuals respond differently to the drug, which may also affect the effectiveness of eltrombopag.

Although eltrombopag is primarily used to treat thrombocytopenia, in some cases it may also cause thrombocytopenia as a side effect. This may be related to the complex effects of drugs on bone marrow hematopoiesis, but the specific mechanism is not fully understood.